In HCC, circEYA3 enhances the radiotherapy resistance by binding to IGF2BP2 and increasing its ability to stabilize DTX3L mRNA, attenuating radiation‐induced DNA damage in HCC cells.359. This evidence concerns the gene IGF2BP2 and hepatocellular carcinoma.